{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:58:40Z","timestamp":1790240320351,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":1984,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","exphem.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.exphem.2016.09.005","type":"journal-article","created":{"date-parts":[[2016,9,21]],"date-time":"2016-09-21T07:26:49Z","timestamp":1474442809000},"page":"45-55.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Constitutive Kit activity triggers B-cell acute lymphoblastic leukemia-like disease in mice"],"prefix":"10.1016","volume":"45","author":[{"given":"Robin R.","family":"Weidemann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rayk","family":"Behrendt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina B.","family":"Schoedel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Roers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Gerbaulet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2016.09.005_bib1","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1146\/annurev.immunol.19.1.595","article-title":"B cell development pathways","volume":"19","author":"Hardy","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.exphem.2016.09.005_bib2","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/0092-8674(91)90032-T","article-title":"Molecular and cellular origins of B lymphocyte diversity","volume":"66","author":"Rolink","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2016.09.005_bib3","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/nri3487","article-title":"New insights into pre-BCR and BCR signalling with relevance to B cell malignancies","volume":"13","author":"Rickert","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.exphem.2016.09.005_bib4","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1146\/annurev.immunol.23.021704.115737","article-title":"Molecular genetics of T cell development","volume":"23","author":"Rothenberg","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.exphem.2016.09.005_bib5","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0140-6736(08)60457-2","article-title":"Acute lymphoblastic leukaemia","volume":"371","author":"Pui","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.exphem.2016.09.005_bib6","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0140-6736(12)62187-4","article-title":"Acute lymphoblastic leukaemia","volume":"381","author":"Inaba","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.exphem.2016.09.005_bib7","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1038\/leu.2015.113","article-title":"The pre-B-cell receptor checkpoint in acute lymphoblastic leukaemia","volume":"29","author":"Eswaran","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2016.09.005_bib8","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.V90.4.1345","article-title":"Stem cell factor and hematopoiesis","volume":"90","author":"Broudy","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2016.09.005_bib9","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1152\/physrev.00046.2011","article-title":"Stem cell factor receptor\/c-Kit: from basic science to clinical implications","volume":"92","author":"Lennartsson","year":"2012","journal-title":"Physiol Rev"},{"key":"10.1016\/j.exphem.2016.09.005_bib10","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2362.2007.01807.x","article-title":"Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria","volume":"37","author":"Valent","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.exphem.2016.09.005_bib11","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1182\/blood-2008-11-189605","article-title":"Mast cell hyperplasia, B-cell malignancy, and intestinal inflammation in mice with conditional expression of a constitutively active kit","volume":"117","author":"Gerbaulet","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2016.09.005_bib12","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/350423a0","article-title":"A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene","volume":"350","author":"Kitamura","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2016.09.005_bib13","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1093\/nar\/25.6.1317","article-title":"B lymphocyte-specific, Cre-mediated mutagenesis in mice","volume":"25","author":"Rickert","year":"1997","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.exphem.2016.09.005_bib14","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jim.2009.06.008","article-title":"ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays","volume":"347","author":"Hu","year":"2009","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.exphem.2016.09.005_bib15","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1084\/jem.173.5.1213","article-title":"Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow","volume":"173","author":"Hardy","year":"1991","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2016.09.005_bib16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0165-2478(99)00035-8","article-title":"B cell development in the mouse from early progenitors to mature B cells","volume":"68","author":"Rolink","year":"1999","journal-title":"Immunol Lett"},{"key":"10.1016\/j.exphem.2016.09.005_bib17","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0092-8674(94)90241-0","article-title":"The expression of Vpre-B\/\u03bb5 surrogate light chain in early bone marrow precursor B cells of normal and B cell-deficient mutant mice","volume":"77","author":"Karasuyama","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2016.09.005_bib18","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1073\/pnas.98.4.1745","article-title":"Induction of pre-B cell proliferation after de novo synthesis of the pre-B cell receptor","volume":"98","author":"Hess","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2016.09.005_bib19","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0092-8674(93)90398-A","article-title":"Immunoglobulin heavy and light chain genes rearrange independently at early stages of B cell development","volume":"72","author":"Ehlich","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2016.09.005_bib20","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0167-5699(98)01330-9","article-title":"B-cell development: a comparison between mouse and man","volume":"19","author":"Ghia","year":"1998","journal-title":"Immunol Today"},{"key":"10.1016\/j.exphem.2016.09.005_bib21","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nature02067","article-title":"Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1","volume":"426","author":"Opferman","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2016.09.005_bib22","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1084\/jem.20052444","article-title":"Lineage specification and plasticity in CD19- early B cell precursors","volume":"203","author":"Rumfelt","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2016.09.005_bib23","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1084\/jem.183.1.187","article-title":"A subpopulation of B220+ cells in murine bone marrow does not express CD19 and contains natural killer cell progenitors","volume":"183","author":"Rolink","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2016.09.005_bib24","doi-asserted-by":"crossref","first-page":"9339","DOI":"10.1158\/0008-5472.CAN-06-3126","article-title":"Cancer stem cells: perspectives on current status and future directions: AACR Workshop on cancer stem cells","volume":"66","author":"Clarke","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2016.09.005_bib25","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1182\/blood-2005-04-1568","article-title":"Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation","volume":"106","author":"Gotlib","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2016.09.005_bib26","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1182\/blood-2005-10-3969","article-title":"Dasatinib (BMS-354825) inhibits KITD816V, an imatinib-resistant activating mutation that triggers neoplastic growth in most patients with systemic mastocytosis","volume":"108","author":"Shah","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2016.09.005_bib27","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/intimm\/6.8.1257","article-title":"IL-2 receptor \u03b1 chain (CD25, TAC) expression defines a crucial stage in pre-B cell development","volume":"6","author":"Rolink","year":"1994","journal-title":"Int Immunol"},{"key":"10.1016\/j.exphem.2016.09.005_bib28","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/381751a0","article-title":"Clonal selection and learning in the antibody system","volume":"381","author":"Rajewsky","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2016.09.005_bib29","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.4049\/jimmunol.1201000","article-title":"A c-Myc and surface CD19 signaling amplification loop promotes B cell lymphoma development and progression in mice","volume":"189","author":"Poe","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2016.09.005_bib30","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ccell.2015.02.003","article-title":"Self-enforcing feedback activation between BCL6 and pre-B cell receptor signaling defines a distinct subtype of acute lymphoblastic leukemia","volume":"27","author":"Geng","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2016.09.005_bib31","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nature06159","article-title":"Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors","volume":"449","author":"Cobaleda","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2016.09.005_bib32","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1126\/science.7660125","article-title":"Inducible gene targeting in mice","volume":"269","author":"K\u00fchn","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.exphem.2016.09.005_bib33","first-page":"1783","article-title":"Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL)","volume":"9","author":"Bene","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2016.09.005_bib34","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/eji.1830250308","article-title":"The distribution of CD10 (NEP 24.11, CALLA) in humans and mice is similar in non-lymphoid organs but differs within the hematopoietic system: absence on murine T and B lymphoid progenitors","volume":"25","author":"Kalled","year":"1995","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.exphem.2016.09.005_bib35","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1038\/sj.leu.2402548","article-title":"Immunoglobulin light chain gene rearrangements display hierarchy in absence of selection for functionality in precursor-B-ALL","volume":"16","author":"van der Burg","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2016.09.005_bib36","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0797-730","article-title":"Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell","volume":"3","author":"Bonnet","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2016.09.005_bib37","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ccr.2008.05.015","article-title":"In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties","volume":"14","author":"le Viseur","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2016.09.005_bib38","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/emmm.201201703","article-title":"Acute B lymphoblastic leukaemia-propagating cells are present at high frequency in diverse lymphoblast populations","volume":"5","author":"Rehe","year":"2013","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.exphem.2016.09.005_bib39","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1126\/science.1142596","article-title":"Tumor growth need not be driven by rare cancer stem cells","volume":"317","author":"Kelly","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.exphem.2016.09.005_bib40","doi-asserted-by":"crossref","first-page":"5580","DOI":"10.1038\/sj.onc.1204640","article-title":"Mechanisms of chromosomal translocations in B cell lymphomas","volume":"20","author":"K\u00fcppers","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2016.09.005_bib41","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1172\/JCI61269","article-title":"The molecular basis of T cell acute lymphoblastic leukemia","volume":"122","author":"Van Vlierberghe","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2016.09.005_bib42","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1470-2045(08)70314-0","article-title":"Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia","volume":"10","author":"Coustan-Smith","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.exphem.2016.09.005_bib43","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/path.2677","article-title":"Variable presence of KITD816V in clonal haematological non-mast cell lineage diseases associated with systemic mastocytosis (SM\u2013AHNMD)","volume":"220","author":"Sotlar","year":"2010","journal-title":"J Pathol"},{"key":"10.1016\/j.exphem.2016.09.005_bib44","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.leukres.2007.04.008","article-title":"Distinct clonal origins of systemic mastocytosis and associated B-cell lymphoma","volume":"31","author":"Kim","year":"2007","journal-title":"Leuk Res"},{"key":"10.1016\/j.exphem.2016.09.005_bib45","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1136\/jcp.2008.058073","article-title":"Systemic mastocytosis with associated myeloproliferative disease and precursor B lymphoblastic leukaemia with t(13;13)(q12;q22) involving FLT3","volume":"61","author":"Tzankov","year":"2008","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.exphem.2016.09.005_bib46","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1525-1578(10)60529-6","article-title":"Demonstration that mast cells, T cells, and B cells bearing the activating kit mutation D816V occur in clusters within the marrow of patients with mastocytosis","volume":"6","author":"Taylor","year":"2004","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.exphem.2016.09.005_bib47","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1182\/blood.V88.3.995.995","article-title":"Neoplastic transformation of normal hematopoietic cells by constitutively activating mutations of c-kit receptor tyrosine kinase","volume":"88","author":"Kitayama","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2016.09.005_bib48","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1128\/MCB.01153-06","article-title":"Neoplasia driven by mutant c-KIT is mediated by intracellular, not plasma\u00a0membrane, receptor signaling","volume":"27","author":"Xiang","year":"2007","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.exphem.2016.09.005_bib49","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1172\/JCI33337","article-title":"Ablation of PI3K blocks BCR-ABL leukemogenesis in mice, and a dual PI3K\/mTOR inhibitor prevents expansion of human BCR-ABL(+) leukemia cells","volume":"118","author":"Kharas","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2016.09.005_bib50","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fonc.2014.00160","article-title":"Ras\/Raf\/MEK\/ERK pathway activation in childhood acute lymphoblastic leukemia and its therapeutic targeting","volume":"4","author":"Knight","year":"2014","journal-title":"Front Oncol"},{"key":"10.1016\/j.exphem.2016.09.005_bib51","doi-asserted-by":"crossref","first-page":"9414","DOI":"10.1073\/pnas.0811761106","article-title":"JAK mutations in high-risk childhood acute lymphoblastic leukemia","volume":"106","author":"Mullighan","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2016.09.005_bib52","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1038\/leu.2012.22","article-title":"Role of intracellular tyrosines in activating KIT-induced myeloproliferative disease","volume":"26","author":"Ma","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2016.09.005_bib53","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa1403088","article-title":"Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia","volume":"371","author":"Roberts","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2016.09.005_bib54","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1073\/pnas.102181599","article-title":"Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression","volume":"99","author":"Bichi","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2016.09.005_bib55","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1182\/blood-2014-05-577122","article-title":"Mouse models in the study of chronic lymphocytic leukemia pathogenesis and therapy","volume":"124","author":"Simonetti","year":"2014","journal-title":"Blood"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X16306154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X16306154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T05:21:36Z","timestamp":1654924896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X16306154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":55,"alternative-id":["S0301472X16306154"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2016.09.005","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Constitutive Kit activity triggers B-cell acute lymphoblastic leukemia-like disease in mice","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2016.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}